Witryna11 kwi 2024 · Get a real-time Organon & Co. (OGN) stock price quote with breaking news, financials, statistics, charts and more. ... Full Company Profile. Financial Performance. In 2024, Organon & Co.'s revenue was $6.17 billion, a decrease of -2.06% compared to the previous year's $6.30 billion. Earnings were $917.00 million, a … Witryna14 kwi 2024 · Organon & Co. Stock Up 1.6 %. OGN stock opened at $23.98 on Friday. The firm has a market capitalization of $6.10 billion, a P/E ratio of 6.68, a price-to-earnings-growth ratio of 0.99 and a beta ...
Organon & Co. (OGN) Stock Price, Quote & News - Stock Analysis
WitrynaOrganon & Co. operates as a pharmaceutical company. The Company develops and produces medicines and other products across a range of areas including … Witrynais consistent with recommendations set forth by the U.S. Department of Health and Human Services and the Code on Interactions with Healthcare Professionals created … At Organon, belonging is the core of our diversity, equity, and inclusion. We … Review the policies of Organon, a global health company dedicated to improving … Meet the leaders who guide Organon, a global health care company dedicated to … See all the locations of Organon, a global health company dedicated to improving … Executive Leadership Team. Our Executive Team manages the strategic direction … Organon has one of the most diverse Boards of Directors in the … Being an ethical company is about much more than simply adhering to the letter … オルガノン株式会社は、女性の皆さん、そのご家族や周囲のコミュニティに、喜 … horizon client network ports
NV Organon Company Profile, Financial and Strategic SWOT …
WitrynaOrganon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health ... Witryna14 kwi 2024 · Organon & Co. Stock Up 1.6 %. OGN stock opened at $23.98 on Friday. The firm has a market capitalization of $6.10 billion, a P/E ratio of 6.68, a price-to … WitrynaPharmaceutical. Headquarters Regions European Union (EU) Founded Date 2024. Founders Saal van Zwanenberg. Operating Status Active. Legal Name Organon & Co. Company Type For Profit. Organon their mission is to deliver medicine and solutions. Their products include reproductive health, heart disease, dermatology, allergies, and … horizon client how to use